Processa Pharmaceuticals, Inc. financial data

Symbol
PCSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
7380 Coca Cola Drive, Suite 106, Hanover, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
Heatwurx, Inc. (to 10/20/2017)
Latest financial report
10-K - Q4 2024 - Mar 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 451 % -42.5%
Debt-to-equity 26.5 % +69.2%
Return On Equity -233 % -64.9%
Return On Assets -184 % -50.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.27M shares +84.5%
Common Stock, Shares, Outstanding 3.7M shares +188%
Entity Public Float 5.8M USD -43.1%
Common Stock, Value, Issued 371 USD +188%
Weighted Average Number of Shares Outstanding, Basic 3.06M shares +133%
Weighted Average Number of Shares Outstanding, Diluted 3.06M shares +133%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
General and Administrative Expense 4.78M USD -15.5%
Operating Income (Loss) -12.1M USD -5.19%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.01M USD -15.2%
Net Income (Loss) Attributable to Parent -11.9M USD -6.55%
Earnings Per Share, Basic -3.87 USD/shares +54.4%
Earnings Per Share, Diluted -3.87 USD/shares +54.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.19M USD -74.7%
Assets, Current 1.87M USD -66.7%
Property, Plant and Equipment, Net 5.02K USD +96.4%
Operating Lease, Right-of-Use Asset 70.7K USD -51.6%
Other Assets, Noncurrent 173K USD -97.8%
Assets 3.23M USD -44.2%
Accounts Payable, Current 881K USD +183%
Accrued Liabilities, Current 579K USD +296%
Liabilities, Current 1.53M USD +110%
Operating Lease, Liability, Noncurrent 21.8K USD -80%
Liabilities 1.53M USD +92.2%
Retained Earnings (Accumulated Deficit) -87.2M USD -15.7%
Stockholders' Equity Attributable to Parent 1.7M USD -66%
Liabilities and Equity 3.23M USD -44.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.05M USD +3.08%
Net Cash Provided by (Used in) Financing Activities 6.26M USD -1.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 3.71M shares +187%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.21M USD -0.56%
Deferred Tax Assets, Valuation Allowance 19.9M USD +12.8%
Deferred Tax Assets, Gross 19.9M USD +12.8%
Operating Lease, Liability 66.9K USD -55.6%
Depreciation 139 USD
Lessee, Operating Lease, Liability, to be Paid 70K USD -56.9%
Operating Lease, Liability, Current 66.9K USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Two 70K USD -24.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 70K USD -24.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.14K USD -73.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%